EP1183540A4 - Methods for predicting and/or diagnosing the risk of gastric cancer - Google Patents

Methods for predicting and/or diagnosing the risk of gastric cancer

Info

Publication number
EP1183540A4
EP1183540A4 EP00924979A EP00924979A EP1183540A4 EP 1183540 A4 EP1183540 A4 EP 1183540A4 EP 00924979 A EP00924979 A EP 00924979A EP 00924979 A EP00924979 A EP 00924979A EP 1183540 A4 EP1183540 A4 EP 1183540A4
Authority
EP
European Patent Office
Prior art keywords
diagnosing
predicting
risk
methods
gastric cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00924979A
Other languages
German (de)
French (fr)
Other versions
EP1183540A1 (en
Inventor
Robert Llewellyn Clancy
Gerald Pang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ONCO ALERT Pty Ltd
Original Assignee
ONCO ALERT Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ONCO ALERT Pty Ltd filed Critical ONCO ALERT Pty Ltd
Publication of EP1183540A1 publication Critical patent/EP1183540A1/en
Publication of EP1183540A4 publication Critical patent/EP1183540A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5406—IL-4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
EP00924979A 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer Withdrawn EP1183540A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ0377A AUPQ037799A0 (en) 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer
AUPQ037799 1999-05-14
PCT/AU2000/000441 WO2000070348A1 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer

Publications (2)

Publication Number Publication Date
EP1183540A1 EP1183540A1 (en) 2002-03-06
EP1183540A4 true EP1183540A4 (en) 2007-07-04

Family

ID=3814581

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00924979A Withdrawn EP1183540A4 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer

Country Status (10)

Country Link
EP (1) EP1183540A4 (en)
JP (1) JP2002544520A (en)
KR (1) KR20020033093A (en)
CN (1) CN1355885A (en)
AU (1) AUPQ037799A0 (en)
BR (1) BR0010558A (en)
CA (1) CA2372761A1 (en)
HK (1) HK1044988A1 (en)
MX (1) MXPA01011721A (en)
WO (1) WO2000070348A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
GB2430031A (en) * 2005-09-07 2007-03-14 Ethicon Inc Diagnostic markers of wound infection
JP2014530350A (en) * 2011-09-14 2014-11-17 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ Means and methods for assessing nephrotoxicity
JP6707248B2 (en) * 2013-12-05 2020-06-10 学校法人北里研究所 Gastric cancer cell detection method and gastric cancer cell detection kit
RU2706118C1 (en) * 2019-04-30 2019-11-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Method for prediction of precancer diseases of stomach
CN117143234B (en) * 2023-08-29 2024-05-03 武汉爱博泰克生物科技有限公司 Monoclonal antibody against rat interleukin-4 protein and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3814395A (en) * 1994-10-20 1996-05-15 Genelabs Diagnostics Pte Ltd Helicobacter pylori diagnostic methods and kits
IT1289578B1 (en) * 1996-12-06 1998-10-15 Sanitaria Scaligera Spa IMMUNOPURIFICATION OF AN ANTIGEN WITH AN APPARENT MOLECULAR WEIGHT OF 16 + - 2 KDA OF THE HELICOBACTER PYLORI AND METHODS FOR ITS

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BLASER MARTIN J ET AL: "Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach", CANCER RESEARCH, vol. 55, no. 10, 1995, pages 2111 - 2115, XP002416860, ISSN: 0008-5472 *
BONTKES H J ET AL: "IGG SUBCLASS RESPONSE TO HELICOBACTER PYLORI IN PATIENTS WITH CHRONIC ACTIVE GASTRITIS AND DUODENAL ULCER", SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, vol. 27, no. 2, 1992, pages 129 - 133, XP009077511, ISSN: 0036-5521 *
FOX JAMES G ET AL: "Mice carrying a truncated Apc gene have diminished gastric epithelial proliferation, gastric inflammation, and humoral immunity in response to Helicobacter felis infection", CANCER RESEARCH, vol. 57, no. 18, 1997, pages 3972 - 3978, XP002416862, ISSN: 0008-5472 *
RUDI JOCHEN ET AL: "Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma", DIGESTIVE DISEASES AND SCIENCES, vol. 42, no. 8, 1997, pages 1652 - 1659, XP002416861, ISSN: 0163-2116 *
See also references of WO0070348A1 *

Also Published As

Publication number Publication date
EP1183540A1 (en) 2002-03-06
BR0010558A (en) 2002-02-19
JP2002544520A (en) 2002-12-24
AUPQ037799A0 (en) 1999-06-10
HK1044988A1 (en) 2002-11-08
MXPA01011721A (en) 2003-09-10
KR20020033093A (en) 2002-05-04
WO2000070348A1 (en) 2000-11-23
CA2372761A1 (en) 2000-11-23
CN1355885A (en) 2002-06-26

Similar Documents

Publication Publication Date Title
EP1931272A4 (en) Methods and systems for determining physiologic characteristics for treatment of the esophagus
GB0000446D0 (en) Early entry
HUP0201757A3 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
IL147683A0 (en) Microarrays and their manufacture
NO992351D0 (en) The method and procedure for installing it
PT1818343E (en) Antibodies against human il-12
AU3367799A (en) Methodology for predicting and/or diagnosing disease
HK1041025A1 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU1465801A (en) Methods for cancer prognosis and diagnosis
EP1175616A4 (en) Methods for the diagnosis and treatment of metastatic prostate tumors
GB2368641B (en) Methods and compositions for assaying analytes
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
AU2002257033A1 (en) Agents and methods for the prevention of initial onset and recurrence of existing cancers
EP1081221A4 (en) Endo-beta-n-acetylglucosaminidase gene
HK1044988A1 (en) Methods for predicting and/or diagnosing the risk of gastric cancer
GB9907687D0 (en) Assays methods and means
GB9803447D0 (en) Cancer diagnosis
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
GB9902662D0 (en) Early entry
AU3429300A (en) Means for diagnosing and treating carcinoma
IL159975A0 (en) Stain-directed molecular analysis for cancer prognosis and diagnosis
AU2003294272A8 (en) Methods for diagnosing the presence or stage of cancer
GB9828564D0 (en) Materials and methods for the treatment and diagnosis of cancer
IL136210A0 (en) Reagent for tumor therapy and/or imaging
IL160242A0 (en) Methods for the treatment and prognosis of leukemia and other cancer types

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/50 20060101ALI20070228BHEP

Ipc: G01N 33/68 20060101AFI20070228BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20070605

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070904